IL18 vaccine for the treatment of various inflammatory conditions.

Details for Australian Patent Application No. 2007320149 (hide)

Owner Theravac Pharmaceuticals AB

Inventors Hellman, Lars

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2007320149

PCT Pub. Number WO2008/060219

Priority 0602414-5 13.11.06 SE

Filing date 12 November 2007

Wipo publication date 22 May 2008

International Classifications

A61K 39/385 (2006.01) Medicinal preparations containing antigens or antibodies - Haptens or antigens, bound to carriers

A61K 38/20 (2006.01) Medicinal preparations containing peptides - Interleukins

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

C07K 14/54 (2006.01) Peptides having more than 20 amino acids

Event Publications

4 June 2009 PCT application entered the National Phase

  PCT publication WO2008/060219 Priority application(s): WO2008/060219

20 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007320166-Closable watertight case

2007320146-Rock drilling method and rock drilling machine